Terms: = Liver cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel AND Treatment
9 results:
1. Dipeptidyl peptidase-8 induces sorafenib resistance via binding with c-rel to mediate NF-κB signaling in hepatocellular carcinoma.
Liu HF; Xie YK; Zhong BY; Zhang JH; Song CX; Liu YW; Yang Y; Xie BH
Cell Biol Int; 2022 Feb; 46(2):213-221. PubMed ID: 34719075
[TBL] [Abstract] [Full Text] [Related]
2. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (rel) clinical network.
Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
[TBL] [Abstract] [Full Text] [Related]
3. [Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline].
Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Makara M
Orv Hetil; 2015 Mar; 156(9):343-51. PubMed ID: 25702254
[TBL] [Abstract] [Full Text] [Related]
4. The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.
Rovida E; Di Maira G; Tusa I; Cannito S; Paternostro C; Navari N; Vivoli E; Deng X; Gray NS; Esparís-Ogando A; David E; Pandiella A; Dello Sbarba P; Parola M; Marra F
Gut; 2015 Sep; 64(9):1454-65. PubMed ID: 25183205
[TBL] [Abstract] [Full Text] [Related]
5. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
[TBL] [Abstract] [Full Text] [Related]
6. Tumor necrosis factor-α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D₃-MARRS to the nucleus.
Grindel BJ; Rohe B; Safford SE; Bennett JJ; Farach-Carson MC
J Cell Biochem; 2011 Sep; 112(9):2606-15. PubMed ID: 21598303
[TBL] [Abstract] [Full Text] [Related]
7. The tyrosine kinase inhibitor sorafenib sensitizes hepatocellular carcinoma cells to taxol by suppressing the HURP protein.
Kuo TC; Lu HP; Chao CC
Biochem Pharmacol; 2011 Jul; 82(2):184-94. PubMed ID: 21549688
[TBL] [Abstract] [Full Text] [Related]
8. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract] [Full Text] [Related]
9. Role of rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
[TBL] [Abstract] [Full Text] [Related]
